Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy

Cancer Invest. 1993;11(2):229-34. doi: 10.3109/07357909309024844.

Authors

P Valent¹, C Sillaber, K Geissler, M Andreeff, A Tafuri, L Vieder, G Schulz, K Lechner, P Bettelheim

Affiliation

¹ First Medical Department, University of Vienna, Austria.

PMID: 8462024
DOI: 10.3109/07357909309024844

No abstract available

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Marrow / drug effects
Bone Marrow / pathology
Drug Administration Schedule
Female
Follow-Up Studies
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Infusions, Intravenous
Leukemia, Myeloid, Acute / blood
Leukemia, Myeloid, Acute / therapy*
Leukocyte Count / drug effects
Male
Middle Aged
Neutrophils / drug effects
Recombinant Proteins / therapeutic use
Remission Induction

Substances

Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor